Deltec Asset Management’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding VIGL
Deltec Asset Management's VIGL Position: Q3 2025 in Review
Deltec Asset Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 30,000 shares — an estimated $239K sold.
Deltec Asset Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $239K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.
- Deltec Asset Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
- Deltec Asset Management sold 30,000 Vigil Neuroscience shares in Q3 2025, an estimated $239K.
- Deltec Asset Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
- Deltec Asset Management's Vigil Neuroscience position peaked at $239K in Q2 2025.
- 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.
Based on Deltec Asset Management's 13F filing for Q3 2025, filed 24 Oct 2025.